C M Bidwell & Associates LTD Repligen Corp Transaction History

C M Bidwell & Associates LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$161.19 - $257.96 $18,536 - $29,665	-115 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$148.08 - $206.57 $174,586 - $243,546	-1,179 Reduced 91.11%	115 $22,000
Q3 2020 Nov 13, 2020	BUY	$122.51 - $158.27 $129,493 - $167,291	1,057 Added 445.99%	1,294 $191,000
Q2 2020 Aug 14, 2020	BUY	$94.33 - $140.48 $22,356 - $33,293	237 New	237 $29,000
Q3 2019 Nov 13, 2019	SELL	$76.65 - $95.51 $75,117 - $93,599	-980 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$54.2 - $85.95 $53,116 - $84,231	980 New	980 $84,000

485

54.1M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $9.21B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

Stay updated on C M Bidwell & Associates LTD with notifications on news.